The medtech major expects its growth rate to more than double in FY27 as it pivots from low-cost consumables to high-value equipment to counter Chinese competition and rising input costs.
Medtech exporter Poly Medicure bets on high-tech pivot and acquisitions to fend off macro headwinds
